SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

  • Kevin Chung

Press/Media

Period12 Mar 2024

Media coverage

1

Media coverage